Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy.
Brose MS, Capdevilla J, Elisei R, Bastholt L, Führer-Sakel D, Leboulleux S, Sugitani I, Taylor MH, Wang Z, Wirth LJ, Worden FP, Bernard J, Caferra P, Colzani RM, Liu S, Schlumberger M.
Brose MS, et al. Among authors: liu s.
Endocr Relat Cancer. 2024 Jun 1:ERC-23-0354. doi: 10.1530/ERC-23-0354. Online ahead of print.
Endocr Relat Cancer. 2024.
PMID: 38828895